Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate the efficacy of 0.2 % digluconate chlorhexidine mouthwash in the prevention of alveolar osteitis following third molar extraction and to evaluate the safety and local tolerability.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02382809
Study type Interventional
Source Pierre Fabre Medicament
Contact
Status Completed
Phase Phase 4
Start date March 2015
Completion date February 2016

See also
  Status Clinical Trial Phase
Completed NCT04091399 - First-in-man Study of Adult Patients Suffered From Alveolar Osteitis Treated Using Stomatological Tamponade Contipro Phase 2
Completed NCT03641482 - NBF Gingival Gel Application After Impacted Lower Third Molar Surgery N/A
Recruiting NCT05615272 - Treatment of Alveolar Osteitis: Traditional or Regenerative? N/A
Not yet recruiting NCT05850650 - The Effect of Post-extraction Collagen Sponge Application on Alveolar Osteitis Phase 2
Recruiting NCT04853589 - Effect of Hyaluronic Acid on the Therapy of Alveolar Osteitis N/A
Completed NCT00118820 - Antibiotic Efficacy in Third Molar Surgery Phase 3
Completed NCT04151147 - Effect of CGF on Frequency of Alveolar Osteitis Following Partially Erupted Mandibular Third Molar Surgery N/A
Enrolling by invitation NCT04476121 - Use of PRF in Treatment of Dry Socket. N/A
Completed NCT04507009 - Clinical Investigation of the Efficacy of CGF and Ozone in the Treatment of Alveolar Osteitis N/A